A newly approved ‘living drug’ could save more cancer patients’ lives
Amtagvi, approved for advanced melanoma, is the first T cell therapy for solid tumors Toni English’s medical team was giddy. It was six weeks after English had completed an experimental cancer treatment, and she had arrived at the Orlando Health Cancer Institute in Florida with her husband to see the results of her latest scan. […]
A newly approved ‘living drug’ could save more cancer patients’ lives Read More »